Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions [Yahoo! Finance]
Eledon Pharmaceuticals, Inc. (ELDN)
Company Research
Source: Yahoo! Finance
43% of the business is held by the top 25 shareholders Institutional ownership in Eledon Pharmaceuticals is 20% Every investor in Eledon Pharmaceuticals, Inc. ( NASDAQ:ELDN ) should be aware of the most powerful shareholder groups. With 57% stake, individual investors possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk). While institutions, who own 20% shares weren't spared from last week's US$48m market cap drop, individual investors as a group suffered the maximum losses Let's delve deeper into each type of owner of Eledon Pharmaceuticals, beginning with the chart below. Check out our latest analysis for Eledon Pharmaceuticals Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices. Eledon Pharmaceuticals already has institutions on the share registry. Indeed, they own a respe
Show less
Read more
Impact Snapshot
Event Time:
ELDN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELDN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELDN alerts
High impacting Eledon Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ELDN
News
- Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare ConferenceGlobeNewswire
- Kidney Transplant Rejection Market to Observe Growth at a CAGR of 4.9% During the Forecast Period (2024-2034) | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human [Yahoo! Finance]Yahoo! Finance
- eGenesis Announces Second Patient Successfully Transplanted with Genetically Engineered Porcine Kidney [Yahoo! Finance]Yahoo! Finance
ELDN
Earnings
- 11/12/24 - Miss
ELDN
Sec Filings
- 2/14/25 - Form SCHEDULE
- 1/13/25 - Form 4
- 1/13/25 - Form 4
- ELDN's page on the SEC website